Bristol-Myers Squibb

Financial Ratio Quarterly Trend Analysis of: Bristol-Myers Squibb Company Stock symbol: BMY Listed on the New York Stock Exchange Introduction: The following report will include provide a financial quarterly trend analysis of Bristol-Myers Squibb Company (BMS) which was founded in 1989, and is based in New York City. This is a publicly traded company on the New York Stock Exchange (NYSE), and their stock symbol is BMY. Bristol-Myers Squibb is currently “ranked 8th among 500 the largest

Bristol-Myers Squibb Company is the outcome of the merging of Bristol-Myers and Squibb Corporation in 1989. Bristol-Myers Squibb is one of the world’s largest pharmaceutical companies head quartered in New York. BMS has global research facilities and manufacturing plants mainly in the United States and Europe (Hoovers, 2015). The corporation has a unique set of strategic principles that help built the company. The company divested in the nutritional and pharmaceutical divisions. BMS expanded its

VRIO Analysis Bristol-Myers Squibb and other pharmaceutical companies have very limited space for the development of competitive advantage. This is due to the limitations set in patents available for new pharmaceuticals. Most chemicals in pharmaceutical products have an equivalently functional substitute making it possible to have multiple products on the market that have identical uses and outcomes. This being the case, pharmaceutical companies can’t rely on one particular product to provide

Products Unlike Gilead that has only one product in its Oncology line, Bristol-Myers Squibb presently have four different drugs namely: Erbitux –an epidermal growth factor receptor (EGFR) antagonist for the treatment of Head & Neck cancer and Colorectal cancer,(2) Opdivo (nivolumab) for the treatment of unresectable or metastic melanoma and lungs cancer, (3) Syrcel( dasatinb) for the treatment of newly diagnosed adult with Philadelphia chromosome –positive (ph+) chronic myeloid leukemia and (4) Yervoy

The core leaders that govern Bristol-Myers Squibb have been stable for the past 4 years. The current Chairman of the Board of Directors, James Cornelius, MBA, was chosen in May 2010 after being CEO of BMS from 2006-2008. The following individuals are board members for BMS. Giovanni Caforio has been the Chief Operations Officer since May 2010, and a board member since 2009. He has a MD degree from the University of Rome. Lewis Campbell is a retired Chairman and former CEO of Textron with a BS in mechanical

company can move to delay the release of its generic comparison through legal and illegal measures. In the following case Bristol-Myers Squibb fell victim to their own anti-competitive practices. Why did Bristol-Myers Squibb and Sanofi-Aventis seek a settlement? Apotex had was near the conclusion of the government mandated 30 month stay brought on by

Introduction Deciding on a career is an important life decision. In order to make an educated decision, reflection on what you want your life to be like is necessary. I would like a job where I can utilize my interest in math and science, have the opportunity to research, create, and develop revolutionary ideas and processes. However, there is more the selecting a career than personal interests. I would like to have a life outside of my job, which would mean I need a structured schedule that is not

Liquidity Ratios The financial health of a business greatly depends on its ability to maintain current commitments and obligations. Liquidity or the ability to generate cash from current assets to meet short-term obligations as well as unforeseen responsibility is important for the subsistence of a company. “A reasonable level of liquidity is essential to the survival of a company, as poor cash control is one of the main reasons for business failure. (Pyke, 2007) Through utilization of tools

To assess the growth and business strategy of Pfizer & Bristol-Myers Squibb, we will make use of Ansoff’s growth matrix. Ansoff’s growth matrix is a valid way to find out which business strategy and growth strategy the business use. The model states which strategy or strategies a company has adopted in order to grow. According to Ansoff there are four possible alternatives a company can use: · Market Penetration – the company seeks to achieve growth within its existing products in their current

Table of Contents 1.0 Introduction 2 2.0 Initial Situation – Case Analysis 2 2.1 The History of Bristol-Myers Squibb (BMS) 2 2.2 Peter R. Dolan 3 2.3 What is Plavix? 3 2.4 Plavix Generic Drug Agreements 4 2.5 Dolan’s Fate 5 3.0 Questions and Answers 6 3.1 Q1) What principles of distributive Negotiation did Sherman use to gain his advantage? 6 3.2 Q2 ) Do you think Sherman behaved ethically? Why or why not? 7 3.3 Q3) What does this incident tell you about the role of deception in negotiation